Device firms that hire third-party companies to conduct performance testing may get less than they’re paying for, the US Food and Drug Administration says in a new letter to industry.
The 20 February alert directs manufacturers and other sponsors of device studies to “carefully evaluate” third-party labs and independently verify all testing results before they are included in regulatory submissions....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?